{"id":"W1988262237","doi":"10.1016/j.ygyno.2010.01.013","title":"A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: A trial of the Chicago, PMH, and California Phase II Consortia","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Sorafenib; Internal medicine; Carcinosarcoma; Carcinoma; Gastroenterology; Oncology; Surgery; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003555963,0.001090853,0.001746288,0.0003993787,0.0008192132,0.00110669,0.0006848344,0.001428885,0.004879771],"category_scores_gemma":[0.002122801,0.0005489826,0.001534994,0.0005040661,0.00102628,0.0007738778,0.0006106645,0.003690992,0.0005997022],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00103805,"about_ca_system_score_gemma":0.003353172,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002780658,"about_ca_topic_score_gemma":0.008668086,"domain_scores_codex":[0.9992173,0.0005030228,0.0000258933,0.0001112095,0.00005700191,0.00008563016],"domain_scores_gemma":[0.9982939,0.0003684765,0.0002297735,0.0001098687,0.00008942436,0.0009085564],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8710211,0.01230638,0.00482597,0.0008591083,0.001697268,0.00009899145,0.0002891303,0.001728568,0.004914735,0.000750679,0.01613645,0.08537164],"study_design_scores_gemma":[0.9638168,0.02979982,0.00278194,0.00003350665,0.0003566885,0.00004367725,0.00003798206,0.0004548604,0.0002472418,0.0001544328,0.002259006,0.00001407747],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9689445,0.007807338,0.00121843,0.004357872,0.0009423543,0.007879934,0.002596186,0.0002377383,0.006015767],"genre_scores_gemma":[0.9633008,0.004487088,0.004971393,0.004402294,0.0007741183,0.01077699,0.003802334,0.00007474426,0.007410322],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004879771,"threshold_uncertainty_score":0.01880598,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03029193866582253,"score_gpt":0.3653861351511101,"score_spread":0.3350941964852875,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}